Baltimore Sun - Rockville's MacroGenics Inc. has signed a deal worth up to $1 billion to develop and commercialize its type-1 diabetes drug with Eli Lilly and Co., the businesses announced today. MacroGenics will receive an initial payment of $41 million from ...